We would love to hear your thoughts about our site and services, please take our survey here.
I do wonder how they can be so bold as to giving forward guidance. Very few other companies are.
('On this basis the Group expects FY20 APBT to be in the range of £35m-£45m'.) it would seem pretty unwise to assume that things will be 'back to normal' just because lockdown has been relaxed. My local high street is still dead, the commuter carpark at the station is still empty and the big 3 floor town shopping center even though it is officially open, half the shops are sill closed and the ones that are open have no customers!
IC mention was only a snippet in a general article on the healthcare sector:
'There is also an increasingly loud argument for the role of biotech tools companies, which help pharma companies identify novel drug targets with increasing efficiency. UK companies including C4X (C4XD) and ReNeuron (RENE) use data and algorithms to find molecules that could be a good starting point for new medicines'.
Regardless of TW and daily SP movements etc, the MMs seem to have been walking this down for the last few weeks.
A mrkt cap of 250m for a company with no revenue to speak of, a test which is not yet ready to market (and will have to be approved for accuracy before it ever gets there) and uncertain demand for it anyhow, is way to high!
Well yes, but it is also business for the 'partner', who will get their costs covered by the loser, and I don't doubt the 'costs' will be as high as possible! So may be they will not demand too much of the actual settlement. Who knows?
'The manufacturer also filed an IP infringement lawsuit against Samsung in February this year. Management noted that it had received a number of offers of third-party funding for the lawsuit, a partner for which has now been selected and a Litigation Funding Agreement (LFA) is now being discussed. It believes the lawsuit will be served in early May, and if successful will result in the company retaining the majority of any award or settlement. '
This co. is a bit of a mystery really. The market obviously has doubts about it. Even the experts don't seem to know exactly what they are up to or if their future plans will pay off. I have just been day trading this for a few weeks now with a measure of success because the AT driven SP bounces around so much.( partly in tune with the overall market level) Last week SP topped 116p which is not far of your 124p. Now we are back to sub 100p. Although ARW bounced back from the ultra lows of 23 March, it has not really made any real upward progress and held it, unlike most of the market. Not quite sure why that is really? Certainly still a long way down from the pre Covid days. If it ever returned to those heights could be a handsome profit from these levels.
All a bit confusing really. Think there has been a bit of a game going on here. If they informed Samsung all that time back re- patent infringement, they probably thought it would bring Samsung running to the negotiating table during the formal sales process. Could have got themselves out of a potential court case/reputation damage/financial loss and snapped up the rest of the IP. Looks like it did not work out that way, hence the court case. Now that NANO have got some big shots on their side, Samsung is going to have to take things more seriously. I don't doubt that they will still string it out to the last minute, hoping NANO goes under. If they did offer an out of court settlement that would tantamount to admitting guilt, and would have to be a similar sum to what a court would award. (if Samsung proven guilty of course!).
Is this company actually going to deliver is the question? Having just listened to the Proactive interview, it is much the same as the one given 6 months ago just after the huge discounted placing! All jam tomorrow. Also this recent jump to the 20's is the first time the 15p placing holders have had a chance to offload at a profit. May account for the subsequent rapid fall. Frankly they seem to be a long way off from 'Creating the world's most productive drug discovery engine'!!!
https://www.investegate.co.uk/c4x-discovery--c4xd-/rns/interim-results/202004290700042360L/
They are only announcing their ' financial' results for the six months ended 31 January 2020. No mention of 'deals' etc. I would be a bit cautious here,...very illiquid share, with only 22m shares odd in free float, they are deadly difficult sell at times!
Same thought struck me actually. Was in Tunbridge Wells town centre today at lunchtime. Normally busy and heaving with people, and usually a que stretching out of Greggs. Now almost completely deserted. Could not possibly worth re opening just yet. But hey, maybe Newcastle is different!
Well thanks for your explanation. I understand a bit more now! Complex instruments and probably best left to those who know whats going on. Could well be in for a long period of low prices it seems. At least CRUD is not leveraged 2x, 3x and even 5x like some of the oil ETFs. Longs and shorts. Deadly if you get it wrong! GLA
As far as I see, CRUD tracks this: https://www.bloomberg.com/quote/BCOMCLTR:IND (A basket of WTI futures contracts) It seems to track quite accurately as well.
Also this site shows prices for futures contracts https://www.barchart.com/futures/quotes/CL*0/futures-prices
I bought here the other day thinking it was impossible that POO could stay this low. How wrong I was! Escaped with a 5% loss, but still tempted to take a position for the future. When the madness is over it will surely bounce back. The worry is you could have a repeat performance when the June contracts come up for expiry i.e go negative!